Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Clinical trial NCT07686263 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07686263
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-03
- Primary completion
- 2029-03-03
- Enrollment
- 472
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.